A recent retrospective analysis of ALK autoantibody concentrations in patients with ALCL found that patients with high titer of anti ALK autoantibodies had longer survival and that ALK autoantibody levels inversely correlated with tumor recurrence (27). The gene discussed is ALK; the disease is anaplastic large cell lymphoma.